Effects of penetration enhancers on in vitro permeability of meloxicam gels

被引:66
作者
Jantharaprapap, R. [1 ]
Stagni, G. [1 ]
机构
[1] Long Isl Univ, Arnold & Marie Schwartz Coll Pharm & Hlth Sci, Div Pharmaceut Sci, Brooklyn, NY 11201 USA
关键词
meloxicam; skin permeability; human cadaver skin; HPLC; menthol;
D O I
10.1016/j.ijpharm.2007.04.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Meloxicam (MLX) was formulated as a 0.3% hydroxypropylcellulose (Klucel (R)) gel. The effect of four different combinations of co-solvents (ethanol, glycol-PEG-400, propylene glycol, and water) on MLX permeability was determined in vitro throughout isopropyl myristate (IPM)saturated cellulose membranes. The gel consisting of 2.5% Klucel, propylene glycol, ethanol, and water (1:1:1) showed superior permeability properties and it was selected as the base-gel to investigate the effect of three levels of the penetration enhancers: dimethylsulfoxide (1, 5, and 10% DMSC), tween20 (1, 2, and 5% TW20), oleic acid (0.4, 1, and 5% OA), and menthol (1, 2.5, and 5% MT). In vitro permeability was determined throughout IPM-saturated cellulose membranes and human cadaver skin. DMSO and TW20 did not improve permeability of MLX compared to the control gel at any of the levels tested. Menthol produced a statistically significant (P<0.001), dose proportional increase in MLX flux with a peak at 5% (2.43 +/- 0.47 mu g/cm(2) /h). Conversely, addition of OA peaked at 1% but decreased at the higher level (5%). There was no significant difference between the MLX amount recovered in stratum corneum and dermis across the different formulations tested. These findings show that the 0.3% MLX gel formulation containing 5% menthol can possibly deliver therapeutically relevant doses of MLX. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:26 / 33
页数:8
相关论文
共 30 条
[1]  
ADDICKS WJ, 1990, TOPICAL DRUG DELIVER
[2]  
AUNGST BJ, 1995, PERCUTANEOUS PENETRA
[3]   PIROXICAM RELEASE FROM DERMATOLOGICAL BASES - INVITRO STUDIES USING CELLULOSE MEMBRANE AND HAIRLESS MOUSE SKIN [J].
BABAR, A ;
SOLANKI, UD ;
CUTIE, AJ ;
PLAKOGIANNIS, F .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1990, 16 (03) :523-540
[4]   The influence of the physicochemical characteristics and pharmacokinetic properties of selected NSAID's on their transdermal absorption [J].
Beetge, E ;
du Plessis, J ;
Müller, DG ;
Goosen, C ;
van Rensburg, FJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 193 (02) :261-264
[5]  
CHOI HK, 2005, EFFECT SALT FORMATIO
[6]   ANTIINFLAMMATORY, ANALGESIC, ANTIPYRETIC AND RELATED PROPERTIES OF MELOXICAM, A NEW NONSTEROIDAL ANTIINFLAMMATORY AGENT WITH FAVORABLE GASTROINTESTINAL TOLERANCE [J].
ENGELHARDT, G ;
HOMMA, D ;
SCHLEGEL, K ;
UTZMANN, R ;
SCHNITZLER, C .
INFLAMMATION RESEARCH, 1995, 44 (10) :423-433
[7]   OLEIC-ACID - ITS EFFECTS ON STRATUM-CORNEUM IN RELATION TO (TRANS)DERMAL DRUG DELIVERY [J].
FRANCOEUR, ML ;
GOLDEN, GM ;
POTTS, RO .
PHARMACEUTICAL RESEARCH, 1990, 7 (06) :621-627
[8]  
FRANZ TJ, 1995, PERCUTANEOUS PENETRA
[9]  
HASHIDA M, 1995, PERCUTANEOUS PENETRA
[10]   ANALYSIS OF DATA ON MEDICAMENT RELEASE FROM OINTMENTS [J].
HIGUCHI, WI .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1962, 51 (08) :802-&